Albireo to present at piper sandler's virtual easl takeaway day

Boston, june 24, 2021 (globe newswire) -- albireo pharma, inc. (nasdaq: albo), a rare liver disease company developing novel bile acid modulators, today announced that ron cooper, president and chief executive officer, will present as part of a fireside chat at piper sandler's virtual easl takeaway day on monday, june 28, at 10:00 a.m. edt.

ALBO Ratings Summary

ALBO Quant Ranking